SR9009 – Stenabolic Review, Results, Dosage | November 2025

Table of Contents

SR9009, more commonly known as Stenabolic, is one of those compounds that seems to live in a gray area of fitness research. It’s not a SARM, not a hormone, and not a traditional performance enhancer, yet it continues to show up in conversations around fat loss, endurance, and metabolic optimization.

What makes SR9009 interesting is that it works through an entirely different pathway than most compounds people discuss in cutting or recomposition research. Instead of targeting androgen receptors, it activates a protein called Rev-ErbA, which plays a central role in how the body regulates energy use, mitochondrial activity, and even sleep cycles.

Most of what we know about SR9009 comes from animal research and experimental models, not large-scale human trials. Still, the data is compelling enough that it’s remained a point of interest for years, especially among researchers exploring metabolism, endurance, and circadian rhythm regulation.

Key Takeaways💡

  • SR9009 is not a SARM—it works by activating Rev-ErbA, a protein tied to metabolism, endurance, and circadian rhythm. ⚡
  • Most effects come from animal research, where SR9009 shows fast-acting changes in endurance, energy use, and mitochondrial activity. 🧬
  • Bioavailability is a major challenge, which is why timing, dosing frequency, and delivery method matter in research discussions. ⏱️
  • Sleep disruption is the most common side effect, since Rev-ErbA influences the body’s internal clock. 🌙
  • Purity varies widely across suppliers, making verified lab testing essential for consistent research outcomes. 🧪

What Is Stenabolic?

Stenabolic is a synthetic compound designed to activate Rev-ErbA, a protein that helps regulate how the body handles energy. Rev-ErbA influences everything from fat storage and mitochondrial output to circadian rhythm and inflammation.

Even though it gets lumped in with SARMs online, SR9009 isn’t hormonal, doesn’t interact with the androgen receptor, and doesn’t act like typical performance-enhancing drugs.

People talk about it because the research hints at:

  • Changes in endurance
  • Noticeable shifts in energy metabolism
  • Fast-acting effects in certain animal studies
  • Potential fat-loss pathways

None of this makes it a “proven” compound, but it does explain why it’s become so popular in fitness research conversations.

How Does Stenabolic Work?

SR9009 has a reputation for acting quickly, especially in research focused on endurance and metabolism, but the reason behind those effects isn’t obvious at first glance. 

Its mechanism centers around a lesser-known pathway that plays a surprisingly large role in how the body handles energy. Once you understand that pathway, the rest of Stenabolic’s reported effects start to make a lot more sense.

What is Rev-ErbA and why does it matter?

Rev-ErbA is a nuclear receptor found mostly in muscle, fat, and liver tissue. It influences:

  • Mitochondrial activity
  • How the body uses stored energy
  • Lipid metabolism
  • Inflammation
  • Sleep–wake patterns

SR9009 binds to Rev-ErbA and essentially boosts its normal activity. Because the receptor controls so many metabolic pathways, this activation can lead to widespread changes in how the body processes fuel.

What does SR9009 do in muscle tissue?

Most of the buzz around SR9009 and endurance traces back to what it appears to do in muscle tissue. In research models, activating Rev-ErbA has been linked to increases in mitochondrial number and efficiency, which essentially means the muscle cells become better at producing and using energy. Researchers have also observed improved oxygen utilization, allowing muscles to work longer before fatigue sets in.

In animal studies, these changes translated into longer run times and slower rates of exhaustion, even without changes in training intensity. That’s why SR9009 is often described as providing an “engine boost.” Rather than acting like a stimulant, it seems to improve how efficiently the muscles themselves generate and use energy, which helps explain the endurance-focused reputation it’s developed in research and anecdotal discussions.

How about in the liver and fat tissue?

Rev-ErbA also plays a major role in how the liver manages fat. When this receptor is activated in research models, it appears to shift the body away from making and storing new fat and toward using what’s already there.

Scientists have observed a slowdown in certain fat-producing pathways, alongside increases in fat oxidation and a greater reliance on stored energy for fuel.

These metabolic shifts help explain why SR9009 often comes up in conversations about fat loss, metabolic efficiency, and body recomposition. By nudging the liver toward better energy management, the compound fits into a broader picture of improved metabolic flexibility rather than acting like a direct fat burner.

Is Stenabolic a SARM?

Stenabolic often gets lumped into SARM conversations, but it’s important to clear this up early: SR9009 is not a SARM. It doesn’t bind to androgen receptors, it doesn’t affect testosterone production, and it doesn’t require post-cycle therapy in research settings. In other words, it doesn’t behave like hormonal performance compounds at all.

So why does it keep showing up alongside SARMs? Mostly because the same communities tend to follow both topics. SR9009 is frequently discussed in “cutting-style” research, and people who are already exploring SARMs often look into metabolic compounds at the same time. That overlap creates confusion, even though the mechanisms are completely different.

From a biological standpoint, Stenabolic sits in its own category. It works through metabolic and circadian pathways, not hormonal ones, which is why grouping it with SARMs is more about online culture than actual science.

What Are the Potential Benefits of SR9009 in Research?

SR9009 shows a surprisingly wide range of effects in early research models, from changes in metabolism to endurance and even mood. Here’s a closer look at the areas scientists pay the most attention to.


Does SR9009 support fat loss in studies?

Early animal studies suggest that SR9009 may:

  • Increase energy expenditure
  • Improve mitochondrial function
  • Reduce fat storage
  • Speed up fat loss even at maintenance calories

This doesn’t automatically apply to humans, but the trend explains why the compound is studied in metabolic research.


Does SR9009 influence cholesterol or cardiovascular markers?

Some early animal studies have looked at how SR9009 may influence cardiovascular-related markers. In these rodent models, researchers noted lower overall cholesterol levels, improved lipid processing, and reductions in certain inflammatory markers.

Because these shifts are generally associated with healthier metabolic and vascular function, scientists studying cardiovascular pathways often reference these findings as part of the reason SR9009 continues to draw interest in preclinical research.


What about endurance and performance?

This is where SR9009 really built its reputation. In animal studies, researchers observed clear improvements in endurance-related markers, including longer running distances, increased time to exhaustion, and measurable boosts in mitochondrial function. In simple terms, the animals were able to go harder for longer before fatiguing.

Those findings line up closely with many anecdotal reports, where people describe feeling lighter on their feet, less winded during cardio, and more capable of sustaining effort in endurance-heavy sessions.

While these experiences don’t replace controlled human data, they help explain why SR9009 is so often discussed in the context of stamina and work capacity rather than raw strength or muscle size.

Are there mood or anxiety effects?

There are also some interesting signals around mood and anxiety, though this area is still much less defined. Preclinical research suggests that Rev-ErbA may play a role in mood regulation, which has led scientists to explore how compounds like SR9009 could influence stress and emotional balance.

Alongside that research, anecdotal reports often mention feeling calmer, experiencing reduced anxiety, or noticing a more stable overall mood while using SR9009.

That said, these effects aren’t universal. Not everyone reports changes in mood, and the experience can vary widely. Still, it comes up often enough in both research discussions and user reports to be considered part of the broader picture when looking at how Rev-ErbA activation may affect the body beyond metabolism and endurance.

What Side Effects Are Associated With SR9009?

SR9009 isn’t known for a long list of side effects, but the ones that do appear usually involve sleep patterns or mild, temporary discomfort. Below is a look at what comes up most in research discussions.


Why does SR9009 sometimes interfere with sleep?

Rev-ErbA affects the circadian rhythm. As a result, the most common side effect is excessive wakefulness, trouble falling asleep, and feeling too “wired” late in the day. Most people experimenting with these compounds in research settings often avoid taking it too close to bedtime.


Are there other reported side effects?

Some reported side effects include headaches:

  • Headaches
  • Mild digestive discomfort
  • Temporary strength dips late in longer cycles

A big issue, however, is product purity. A lot of “side effects” circulating in forums trace back to mislabeled or contaminated products. This is why verified lab testing is essential.

What Dosage and Cycle Length Are Typically Discussed in Research Circles?

Because SR9009 isn’t approved for human use, there is no official dosing protocol. However, in community and laboratory contexts, you’ll usually see:

  • 20–30 mg per day
  • 8-week testing windows

The total amount is usually split because of the compound’s short half-life.

What Is the SR9009 Half-Life?

The estimated half-life is 4–6 hours. This is short enough that researchers often divide doses into morning, midday, and early evening. This makes the compound easier to evaluate across consistent time intervals.

Why Do People Talk So Much About SR9009’s Bioavailability?

Bioavailability is one of the biggest challenges researchers face when working with SR9009. In its standard oral form, the compound is absorbed poorly, and a significant portion is broken down before the body can make use of it. 

This is why researchers often emphasize that oral SR9009 doesn’t remain active for long and may require creative approaches to achieve consistent exposure in a study.

To work around these limitations, some research groups use sublingual liquid administration, since holding the liquid under the tongue allows more of the compound to bypass the digestive system. 

Others explore splitting the total amount into multiple smaller doses across the day to maintain more stable levels. Injectable versions of SR9009 also exist, but they are still experimental, difficult to source reliably, and not standardized across suppliers.

For now, the bioavailability issue remains one of the main reasons researchers approach SR9009 with caution and why results can vary widely depending on the format and method of administration.

How Does Oral SR9009 Compare With Injectable Versions?

Injectable SR9009 is often described as more direct because it bypasses digestion and first-pass metabolism, which means researchers may observe stronger effects at lower amounts. 

Even so, injectables come with several complications. Quality can vary significantly between suppliers, they are more difficult to source, and they require technical handling that not all research environments are equipped for. 

On top of that, there is no widely accepted or standardized dosing format for injectable SR9009, making consistency harder to achieve. 

For these reasons, most researchers continue to rely on oral or sublingual versions, which are easier to work with and far more accessible for controlled testing.

How Is SR9009 Different From SR9011?

SR9011 is essentially a follow-up compound to SR9009 designed to improve bioavailability. The tradeoff is that while SR9011 may absorb better, it has far less published research behind it. Most of the interest and literature still centers around SR9009.

Can SR9009 Be Stacked With SARMs During Research?

Since SR9009 is non-hormonal, it’s often paired with SARMs that help preserve muscle mass during calorie deficits. Two common stacks mentioned in forums and research logs include:

  • SR9009 + Ostarine (MK-2866): Popular for metabolism-focused studies.
  • SR9009 + LGD-4033: Used in contexts where lean mass preservation is a priority.

These combinations are entirely based on community research patterns and should not be taken as recommendations. They simply reflect the environment in which SR9009 is commonly studied.

Where to Buy Reliable SARMs

Due to its volatility, short half-life, and ongoing developmental status in the metabolism-focused research space, Stenabolic (SR9009 and SR9011) is not currently offered on any of SARMGuide’s recommended platforms. These compounds remain difficult to standardize, and purity varies widely across suppliers, which is why we do not list them on our verified sources page.

However, researchers looking for more stable and consistently tested compounds often consider several better-established SARMs. These have clearer manufacturing standards, more available lab reports, and significantly stronger third-party testing histories.

Below are the SARMs most frequently sourced through the platforms we monitor:

SR-9011

SR-9011 is a synthetic REV-ERB agonist studied for its ability to modulate the REV-ERBα and REV-ERBβ nuclear receptors. Research explores its influence on circadian rhythm regulation, metabolic gene expression, lipid metabolism, glucose utilization, and transcriptional pathways linked to cellular energy balance. Its structure and behavior closely resemble SR-9009, though SR-9011 is often investigated for its improved bioavailability in certain study models.

Disclaimer: This content is for informational purposes only. SR-9011 has not been approved for medical use by the FDA or other regulators. For research use only.


➡️ Buy Now

Ostarine / MK-2866

Ostarine, also known as MK-2866, is a selective androgen receptor modulator studied for its potential to influence muscle preservation, lean mass development, and tissue-specific androgen receptor activity in research models. It is widely used in laboratory settings to examine anabolic signaling pathways due to its high oral bioavailability and selective receptor interaction.

Disclaimer: This content is for informational purposes only. Ostarine has not been approved for medical use by the FDA or other regulators. For research use only.

➡️ Buy Now

Ligandrol / LGD-4033

LGD-4033, commonly referred to as Ligandrol, is a selective androgen receptor modulator researched for its strong affinity to androgen receptors involved in muscle and strength development. It is often used in laboratory environments to explore anabolic pathways, muscle-preservation models, and strength-related signaling mechanisms.

Disclaimer: This content is for informational purposes only. LGD-4033 has not been approved for medical use by the FDA or other regulators. For research use only.

➡️ Buy Now

What Practical Tips Help Researchers Get Consistent Results?

A few things come up again and again in research reports:

  • Keep diet consistent when studying metabolic changes
  • Split doses evenly across the day
  • Use sublingual administration for liquids if evaluating oral absorption
  • Source verified products with COAs
  • Take notes and track research conditions

Consistency is everything. Even minor differences like diet changes, training volume, and inconsistent timing can alter results.

What Should Someone Expect When Studying SR9009?

Across animal studies and anecdotal research logs, a few consistent patterns tend to show up. Endurance-related effects often appear early, sometimes within the first phase of observation, while fat-loss–related changes usually take a bit longer and become noticeable after a week or two. Some reports also mention improvements in mood or a calmer mental state, though this isn’t universal and doesn’t occur in every case.

Sleep timing comes up frequently as an important variable, since SR9009 interacts with pathways tied to circadian rhythm. Bioavailability remains the biggest limitation researchers point out, as absorption and exposure can vary widely depending on form and timing.

Overall, there’s enough evidence to suggest that SR9009 has real biological activity, but not enough clarity yet to fully understand how these effects translate from animal models to humans.

 
 

Conclusion

SR9009 is one of the more unique compounds in the metabolism research space. It doesn’t act like a SARM, doesn’t influence hormones, and doesn’t require the same considerations. Instead, it works through Rev-ErbA, a metabolic switch with wide-reaching effects in animal studies.

Most of what people discuss like fat loss, endurance, and mood comes from preclinical models and anecdotal logs. For now, it remains a compound with interesting potential but limited human data. 

Anyone working with SR9009 should focus on consistency, proper sourcing, and careful observation because everything else is still being explored.

FAQ's

Frequently Asked Questions

Because of its short half-life, most split the total into three evenly spaced servings.

Liquid solutions are often used sublingually to improve absorption.

Liquid solutions are often used sublingually to improve absorption.

Roughly 4–6 hours.

Most reports describe 8-week testing periods.

DISCLAIMER: The information provided above is not intended to substitute professional medical advice, diagnosis, or treatment. Always seek your physician’s advice or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have seen or read.We bear no responsibility or liability for your use of any compound. 

more insights